SINAInnovations

The Icahn School of Medicine at Mount Sinai is hosting its sixth annual SINAInnovations conference. This year’s theme “Cancer” will include keynote addresses, short talks, panel discussions and breakout sessions featuring international thought leaders across the range of relevant domains. Sessions and lectures will include: Cancer Immunology; Immunotherapy & Immune Monitoring; Viruses and Cancer; Cancer Genetics and Genomics; Personalized omics, Cancer Risk and Management; Novel Therapeutics in Cancer and Post Genomic Age; and Cancer Survivorship and Disparities. The conference will define the astonishing advances in cancer and outline solutions to overcome obstacles to progress.

 


2016 SINAInnovations Overview

The 2016 SINAInnovations, with the theme of “Therapeutic Discovery”, included keynote addresses, short talks, panel discussions and lunchtime breakout sessions featuring international thought leaders across the range of relevant domains. Sessions and lectures included: Drug Development in Academia; Target Identification and Validation; Industry-Academic Medical Center Partnerships; Funding Drug Discovery; Health Disparities and Drug Discovery for the Developing World; Clinical Trial Advances and Novel First-in-man Approaches, and Therapeutic Frontiers in Oncology. The conference defined the astonishing advances in drug discovery and outlined solutions to overcome obstacles to progress.

Tuesday October 25, 2016

 

7:30 - 8:15 am: Breakfast/Registration
Location: Annenberg West Lobby

8:15 - 8:30 am: Welcome Remarks
Kenneth L. Davis, President and CEO, Mount Sinai Health System
Dennis S. Charney, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai; President for Academic Affairs, Mount Sinai Health System

8:35 - 9:05 am: Keynote Address – Therapeutic Frontiers in Mental Health
Introduction: Eric J. Nestler, Dean for Academic and Scientific Affairs, Icahn School of Medicine at Mount Sinai
Speaker: Karl Deisseroth, D.H. Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences, Stanford University; Investigator, Howard Hughs Medical Institute

9:10 - 10:05 am: Panel Discussion – Drug Development in Academic Medical Centers
Moderator:
 Paul J. Kenny, Director, Experimental Therapeutics Institute, Icahn School of Medicine at Mount Sinai
Panelists:

  • Aled Edwards, CEO, Structural Genomics Consortium
  • Kevin Grimes, Co-Director, SPARK Translational Research Program; Associate Professor, Department of Chemical and Systems Biology, Stanford University School of Medicine
  • Kenneth Kaushansky, Senior Vice President for Health Sciences; Dean, School of Medicine, Stony Brook University
  • Craig W. Lindsley, Professor and Co-Director, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University
  • Satwant K. Narula, Former Vice President, Immunosciences and Fibrotic Diseases, Bristol-Myers Squibb
  • Rupert Vessey, Exec VP and President, Global Research and Early Development, Celgene

10:10 - 10:40 am: Break
Location:
 Annenberg West Lobby

10:45 - 11:15 am: Keynote Address – From Genomics to Therapeutics: Uncovering and Manipulating the Circuitry of Non-Coding Disease Variants and Cancer
Introduction: Marta Filizola, Dean, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai
Speaker: Manolis Kellis, Professor, MIT Computer Science and Artificial Intelligence Lab; Institute Member, Broad Institute of Massachusetts Institute of Technology and Harvard

11:20 am - 12:15 pm: Panel Discussion – Target Identification, Validation and First in Man Approaches 
Moderator: Lakshmi A. Devi, Dean for Academic Development and Enrichment, Icahn School of Medicine at Mount Sinai
Panelists:

  • Avi Ma'ayan, Professor, Department of Pharmacological Sciences; Director, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai
  • Harlan Robins, Program Head, Full Member, Computational Biology, Fred Hutchinson Cancer Research Center
  • Kári Stefánsson, President, Chief Executive Officer, and Director, deCODE Genetics
  • Jared L. Sterneckert, Group Leader, Induced Pluripotent Stem Cells and Neurodegenerative Disease, DFG-Center for Regenerative Therapies, Technische Universität Dresden

12:20 - 12:50 pm: Keynote Address – Beyond CRISPR
Introduction: 
Scott L. Friedman, Dean for Therapeutic Discovery, Icahn School of Medicine at Mount Sinai
Speaker: 
George Church, Professor, Department of Genetics, Harvard Medical School and Massachusetts Institute of Technology

12:50 - 1:15 pm: Pick-Up Lunch
Location:
 Davis Conference Center, Hess Building

1:15 - 2:15 pm: Trainee Forum Breakout Sessions
Location:
 Davis Conference Center, Hess Building

2:30 - 4:45 pm: Trainee Forum Keynote Address and Young Innovators Pitch Competition
Location:
 Davis Conference Center, Hess Building

5:00 - 7:30 pm: Networking Reception and Mount Sinai Entrepreneur Resource Fair
Location:
 Davis Conference Center, Hess Building

 

 

Wednesday October 26, 2016

 

7:30 - 8:30 am: Breakfast/Registration
Location:
 Annenberg West Lobby

8:30 - 9:00 am: Keynote Address – Therapeutics Frontiers in Oncology (Rudin-Kase Dean’s Lecture*)
Introduction: Miriam Merad, Director, Precision Immunology Institute, Icahn School of Medicine at Mount Sinai
Speaker: Drew M. Pardoll, Abeloff Professorship of Oncology; Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy; Co-Director, Cancer Immunology, Johns Hopkins School of Medicine

9:05 - 10:00 am: Panel Discussion – Novel Approaches to Drug Screening
Moderator:
 Robert J. DeVita, Director of Medicinal Chemistry, Experimental Therapeutics Institute, Icahn School of Medicine at Mount Sinai
Panelists:

  • Michelle Arkin, Associate Professor, Pharmaceutical Chemistry; Director of Biology, Small Molecule Discovery Center, University of California San Francisco
  • Michael A. Foley, Sanders Director, Tri-Institutional Therapeutics Discovery Institute
  • Geraldine A. Hamilton, President and Chief Scientific Officer, Emulate Inc.
  • Peter Hodder, Executive Director, Discovery Technologies, Amgen
  • David Israel, Director, Cell and Molecular Technologies, GlaxoSmithKline

10:05 - 11:00 am: Panel Discussion – Clinical Trials - Evolving Models and Ethical Issues
Moderator:
 Janice L. Gabrilove, Director, Clinical Research Education Programs, Icahn School of Medicine at Mount Sinai
Panelists:

  • Daniel Burkhoff, Director, Heart Failure Hemodynamics and MCS Research, Cardiovascular Research Foundation
  • Gwen L. Nichols, Site Head, Translational Medicine Oncology, Roche Pharmaceutical Research and Early Development
  • Nicholas J. Schork, Professor and Director of Human Biology, J. Craig Venter Institute
  • Gilles Tamagnan, Institute for Neurodegenerative Disorders

11:00 - 11:30 am: Break
Location: 
Annenberg West Lobby

11:30 am - 12:00 pm: Keynote Address – Health Disparities and the Developing World
Introduction: Prabhjot Singh, Director, Arnhold Institute for Global Health, Icahn School of Medicine at Mount Sinai
Speaker: Suprotik Basu, Chief Executive Officer, UN Secretary-General's Special Envoy for Health in Agenda 2030 and for Malaria

12:05 - 1:00 pm: Panel Discussion – Funding Therapeutic Discovery in Academia
Moderator: Erik Lium, Senior Vice President, Mount Sinai Innovation Partners, Icahn School of Medicine at Mount Sinai
Panelists:

  • Lisa Boyette, CEO, Curable
  • Barbara Mroczkowski, Special Assistant to the Deputy for Clinical and Translational Research, National Cancer Institute
  • Jeffrey S. Nye, Vice President, Neuroscience Innovation and Scientific Partnership Strategy, Johnson & Johnson Innovation; Adjunct Associate Professor, Northwestern University
  • Carlo Rizzuto, Partner, Versant Ventures
  • Amir Tamiz, Program Director, National Institute of Neurological Disorders and Stroke, Office of Translational Research

1:00 - 1:30 pm: Presentations for SINAIMedmaker Challenge and Young Innovators Pitch Competition

1:30 - 1:45 pm: Closing Remarks
Scott L. Friedman, Dean for Therapeutic Discovery, Icahn School of Medicine at Mount Sinai

*The Rudin-Kase Dean's Lecture Series at Icahn School of Medicine at Mount Sinai is generously supported by a grant from the Louis and Rachel Rudin Foundation.

 

HITLAB Innovators Summit, collaborating partner of SINAInnovations

The HITLAB Innovators Summit brings together leaders in public health, medicine, technology, and design to discuss health issues and solutions in a three-day live event. The Summit offers a series of carefully curated talks, panels, and collaboration opportunities to engage the most creative minds in health and technology.

 

2016 Hitlab Innovators Summit: New York

November 29 – December 1, 2016

Lerner Hall, Columbia University, New York City

2920 Broadway (At 115th Street) NY, NY 10027

2016 Event Organizers: Scott L. Friedman, Lakshmi A. Devi, Robert J. Devita, Janice L. Gabrilove, Paul J. Kenny, Erik Lium, Miriam Merad

If you have any questions, you can contact us at sinainnovations@mssm.edu.